))
Treatment-Resistant Depression: What is the role of Ketamine, DBS, VNS, TMS, and Psychedelics? Special Guest Dr. Scott Aaronson
Manage episode 306422965 series 3003231
Content provided by Journal Psychedelic Psychiatry LLC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Journal Psychedelic Psychiatry LLC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Join the Editors of The Journal of Psychedelic Psychiatry as they discuss Treatment-Resistant Depression with Special Guest and Psychiatrist Dr. Scott Aaronson.
Dr. Scott Aaronson obtained his M.D. from Harvard University in 1981. He is currently an Associate Professor at The University of Maryland School of Medicine, a Distinguished Life Fellow of the American Psychiatric Association, a Fellow of The American College of Psychiatrists. He serves on the board of the American Society of Clinical Psychopharmacology and the board of the Clinical TMS Society. He currently is the Director of Clinical Research for The Retreat at Sheppard Pratt.
Referenced Articles on Treatment-Resistant Depression:
https://www.ncbi.nlm.nih.gov/pubmed/30974339
Follow us:
Website: https://www.journalofpsychedelicpsychiatry.org/
Twitter: https://twitter.com/psychedelic_org
Facebook: https://www.facebook.com/JournalofPsychedelicPsychiatry/
Instagram: https://www.instagram.com/journalpsychedelicpsychiatry/
--- Support this podcast: https://podcasters.spotify.com/pod/show/journalofpsychedelic/support33 episodes
Share
